Osimertinib benefit in EGFR-mutant NSCLC patients with T790M-mutation detected by circulating tumour DNA.
| Image |  |
|---|---|
| Description | scientific article published on 18 January 2017 |
| Author/s |
author: Andrew Lawson Maria-Virginia Bluthgen |
| Publication date | January 18, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |